Related Experiment Video
Updated: Feb 11, 2026

Full-Endoscopic Interlaminar Approach for Decompression of Lateral Recess Stenosis
Published on: February 24, 2023
Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness
David Owen1, Ana Töpf1, Veeramani Preethish-Kumar2
1Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Abstract:
Congenital myasthenic syndrome (CMS) is a heterogeneous disorder that causes fatigable muscle weakness. CMS has been associated with variants in the MuSK gene and, to date, 16 patients have been reported. MuSK-CMS patients present a different phenotypic pattern of limb girdle weakness. Here, we describe four additional patients and discuss the phenotypic and clinical relationship with those previously reported. Two novel damaging missense variants are described: c.1742T > A; p.I581N found in homozygosis, and c.1634T > C; p.L545P found in compound heterozygosis with p.R166*. The reported patients had predominant limb girdle weakness with symptom onset at 12, 17, 18, and 30 years of age, and the majority exhibited a good clinical response to Salbutamol therapy, but not to esterase inhibitors. Meta-analysis including previously reported variants revealed an increased likelihood of a severe, respiratory phenotype with null alleles. Missense variants exclusively affecting the kinase domain, but not the catalytic site, are associated with late onset. These data refine the phenotype associated with MuSK-related CMS.
Insights
Congenital myasthenic syndrome (CMS) linked to the MuSK gene presents with limb girdle weakness. Novel variants and a meta-analysis refine understanding of MuSK-CMS phenotypes and treatment responses.
Area of Science:
- Neurology
- Genetics
- Rare Diseases
Background:
- Congenital myasthenic syndrome (CMS) is a group of inherited disorders causing muscle weakness.
- MuSK gene variants are a known cause of CMS, with a distinct limb girdle weakness pattern.
- Previous reports detail 16 patients with MuSK-CMS.
Related Concept Videos
Weak Base Solutions
Histone Variants at the Centromere
Weak Acid Solutions
Titration of a Weak Acid with a Weak Base
As a result, there is no simple...
Titration Calculations: Weak Acid - Strong Base
For the titration of 25.00 mL of 0.100 M CH3CO2H with 0.100 M NaOH, the reaction can be represented as:
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

